Heather D. Turner, SVP, General Counsel & Secretary at Orexigen Therapeutics, Inc. (OREX), sold 31,388 shares at $6.00 ($183K) on 2014-11-25, disclosed to the SEC on 2014-11-26.
Scheduled sale ($183k) by SVP, General Counsel & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.77 | 24,006 | $139K | 75.8% |
| 2 | $6.00 | 7,382 | $44K | 24.2% |
| Total | $5.82 avg | 31,388 | $183K | 100% |
| Filing → |
| OREX | SELL | 2014-12-04 | $136K | — | Filing → |
| OREX | SELL | 2014-09-22 | $1.3M | — | Filing → |
| OREX | SELL | 2012-07-19 | $633K | — | Filing → |